Fundraising Fox

Cure51

4 known investors

cure51.com ↗

Cure51 studies exceptional cancer survivors to understand the biology of long-term survival, running clinical research that emphasizes patient population diversity. The company works with oncology research institutions to investigate the mechanisms behind extraordinary cancer survival.

AI & Machine LearningBiotechHealthtech

Investors · 4

Hitachi VenturesMunich
Kima VenturesParis · $50K – $5M
LifeX VenturesSan Franciscovia Inaki Berenguer · inferred
Sofinnova PartnersreportedParis · $540K – $27M

In the news

Cure51 Raises 15 Million Euros in a Round Led by Sofinnova Partnersborn2invest.com · Mar 2024Cure51 raises a €15M seed round aiming to crack the code on cancer survival | TechCrunchtechcrunch.com · Mar 2024Cure51 Raises €15M in Seed Fundingfinsmes.com · Mar 2024Paris-based Cure51 raises €15M in seed funding - Tech.eutech.eu · Mar 2024Paris-based Cure51 raises €15 million to develop first-in-class treatments from exceptional cancer survivors | EU-Startupseu-startups.com · Mar 2024Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease - Sharecast.comsharecast.com · Mar 2024

Frequently asked questions

What does Cure51 do?
Cure51 studies exceptional cancer survivors to understand the biology of long-term survival, running clinical research that emphasizes patient population diversity. The company works with oncology research institutions to investigate the mechanisms behind extraordinary cancer survival.
Who are Cure51's investors?
Cure51's investors include Hitachi Ventures, Kima Ventures, LifeX Ventures, Sofinnova Partners.